Sanofi S.A. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi S.A. with three other
pharmaceutical manufacturers in Europe:
sales of 41.40 billion Euros [US$49.58 billion]
of which 46%
of UNITED KINGDOM
(£34.10 billion [US$46.97 billion]
of which 50%
was Pharmaceuticals), and
based in SWITZERLAND
(46.58 billion Swiss Francs [US$50.46 billion]
of which 78%
was Innovative Medicines).
During the year ended December of 2020, sales at
Sanofi S.A. were 37.37 billion Euro (US$44.75 billion).
decrease of 0.7%
versus 2019, when the company's sales were 37.63 billion Euro.
The sales level in 2020 was fairly close to the level five years ago: in 2015, Sanofi S.A. had sales
of 34.86 billion Euro.
Contributing to the drop in overall sales was the 6.3% decline
in Consumer Healthcare, from 4.69 billion Euro to 4.39 billion Euro.
There were also decreases in sales in
Pharmaceuticals (down 0.1% to 25.67 billion Euro)
However, these declines were partially offset by the increase in sales of
Vaccines (up 4.2% to 5.97 billion Euro)